Apexigen Inc.

NASDAQ: APGN · Real-Time Price · USD
0.39
0.04 (9.86%)
At close: Aug 22, 2023, 9:59 PM

Apexigen Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-32.07M -28.92M
Depreciation & Amortization
110K 105K
Stock-Based Compensation
1.88M 1.14M
Other Working Capital
-2.33M 2.19M
Other Non-Cash Items
1.4M 528K
Deferred Income Tax
n/a 204K
Change in Working Capital
-2.01M 3.03M
Operating Cash Flow
-30.69M -23.9M
Capital Expenditures
-57K -54K
Cash Acquisitions
n/a 58.08M
Purchase of Investments
-18.95M -20.18M
Sales Maturities Of Investments
29.96M 42.26M
Other Investing Acitivies
n/a -58.08M
Investing Cash Flow
10.96M 22.02M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
11.1M 37K
Financial Cash Flow
11.1M 37K
Net Cash Flow
-8.64M -1.84M
Free Cash Flow
-30.75M -23.96M